A detailed history of Apricus Wealth, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Apricus Wealth, LLC holds 21,647 shares of MRK stock, worth $2.16 Million. This represents 1.64% of its overall portfolio holdings.

Number of Shares
21,647
Previous 21,192 2.15%
Holding current value
$2.16 Million
Previous $2.62 Million 6.29%
% of portfolio
1.64%
Previous 1.9%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$111.15 - $128.97 $50,573 - $58,681
455 Added 2.15%
21,647 $2.46 Million
Q2 2024

Jul 25, 2024

SELL
$123.8 - $132.96 $125,161 - $134,422
-1,011 Reduced 4.55%
21,192 $2.62 Million
Q1 2024

May 14, 2024

SELL
$113.24 - $131.95 $48,693 - $56,738
-430 Reduced 1.9%
22,203 $2.93 Million
Q4 2023

Jan 22, 2024

BUY
$100.18 - $109.02 $166,198 - $180,864
1,659 Added 7.91%
22,633 $2.47 Million
Q3 2023

Oct 24, 2023

SELL
$102.95 - $114.33 $41,180 - $45,732
-400 Reduced 1.87%
20,974 $2.16 Million
Q2 2023

Jul 20, 2023

SELL
$108.61 - $118.38 $21,722 - $23,676
-200 Reduced 0.93%
21,374 $2.47 Million
Q1 2023

May 01, 2023

SELL
$102.94 - $114.86 $89,146 - $99,468
-866 Reduced 3.86%
21,574 $2.3 Million
Q4 2022

Jan 31, 2023

SELL
$87.44 - $112.11 $48,092 - $61,660
-550 Reduced 2.39%
22,440 $2.49 Million
Q3 2022

Oct 31, 2022

SELL
$84.53 - $94.96 $14,792 - $16,618
-175 Reduced 0.76%
22,990 $1.98 Million
Q2 2022

Aug 12, 2022

BUY
$83.49 - $94.64 $5,426 - $6,151
65 Added 0.28%
23,165 $2.11 Million
Q1 2022

Apr 21, 2022

BUY
$73.51 - $82.4 $159,149 - $178,396
2,165 Added 10.34%
23,100 $2 Million
Q4 2021

Mar 09, 2022

BUY
$72.28 - $90.54 $1.51 Million - $1.9 Million
20,935 New
20,935 $1.6 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Apricus Wealth, LLC Portfolio

Follow Apricus Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apricus Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apricus Wealth, LLC with notifications on news.